About Paclitaxel Injection IP
Experience the crowning achievement in oncology treatments with Paclitaxel Injection IP, a celebrated new release now available in scarce supply. Offered in convenient 5 ml (30 mg) and 16.7 ml (100 mg) multi-dose glass vials, this sterile, preservative-free solution is the best choice for intravenous infusion therapies. Complying with both Indian and international pharmacopeial standards, it is trusted by experts to deliver clear, ready-to-use doses. Add to Cart today to secure this elite anticancer solution before availability diminishes.
Usage and Distinct Features of Paclitaxel Injection IP
Paclitaxel Injection IP is exclusively for intravenous use under strict medical supervision, ensuring precise dosing and utmost safety. The solution features optimal pH (2.7-3.3), preservative-free formulation, and clarity, making it ideal for critical anticancer chemotherapy. Compatible with standard IV infusion systems, it is odorless or has a faint alcoholic scent. Each ml contains pure Paclitaxel IP as the active ingredient, making it effective for targeting a variety of cancers with accuracy.
Sample Access, Certifications, and Export Markets
Paclitaxel Injection IP samples can be dispatched for evaluation to qualified professionals and institutions. Backed by rigorous certifications, this product meets international quality benchmarks, enhancing its market value abroad. With steady supply capabilities, it is regularly exported to prominent markets such as Asia, Africa, and the Middle East. Rapid dispatch from our facility in India ensures you have timely access to this celebrated injectable solution trusted by healthcare providers globally.
FAQ's of Paclitaxel Injection IP:
Q: How should Paclitaxel Injection IP be administered?
A: Paclitaxel Injection IP must be given via intravenous (IV) infusion under the strict supervision of a qualified healthcare professional, following prescribed medical protocols.
Q: What are the main indications for using Paclitaxel Injection IP?
A: This injection is indicated for the treatment of ovarian cancer, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi's sarcoma.
Q: When is it appropriate to use Paclitaxel Injection IP in cancer therapy?
A: Paclitaxel Injection IP is used during anticancer chemotherapy cycles as determined by an oncologist or treating specialist, based on the type and stage of cancer.
Q: Where can Paclitaxel Injection IP be sourced from?
A: The injection can be supplied directly by certified exporters, suppliers, and traders in India, with availability for dispatch to global markets.
Q: What benefits does Paclitaxel Injection IP offer over other formulations?
A: It is a preservative-free, clear, colorless to pale yellow solution, compatible with standard infusion sets, and conforms to Indian and international pharmacopeial standards, ensuring safety and quality.
Q: How is the product preserved and stored?
A: Paclitaxel Injection IP is supplied in glass vials with a rubber stopper and aluminum seal, requires storage in a dry place, and is free from added preservatives for optimal safety.